Cannabis Law Report

JUNE 25, 2021

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Enforcement.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

Cannabis Law Report

NOVEMBER 2, 2021

We wanted to investigate, so after collecting samples from online stores and brick-and-mortar smoke shops, we commissioned FESA Labs to perform independent testing on 51 delta-8 products. Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? Table of Contents. Executive Summary.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

FEBRUARY 15, 2019

We have also written to the California Attorney General as well as the General Counsel for all three of the agencies in California that regulate the cannabis industry regarding this topic. These three agencies are: Bureau of Cannabis Control “BCC” [Retail, Retail-Delivery, Distribution – Packaging], California Dept.

Education 40

Education Cannabis Collective Law 40

Marijuana Packaging

OCTOBER 25, 2018

California’s New Packaging Rules and Regulations. The changes place the brunt of the responsibility for child resistance on dispensaries, giving manufacturers and producers until 2020 to get their packaging up to state compliance standards. Edibles will need child-resistant packaging designed to run the duration of their expected use.

Cannabinoids 40

Cannabinoids Packaging Recreational Cannabis 40

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). With our extensive preclinical development package in hand, we are positioned to efficiently pursue additional indications for INM-755. For more information, visit www.inmedpharma.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Meadow

DECEMBER 24, 2017

I don’t really know, as Hezekiah was alluding to on the collective question, people have to have their come-to-Jesus moment. So we’re talking tinctures, we’re talking topicals, those types of products, we’re not going to see a TCH cap in those first six months. Are they worried about fines from the state or from their local government?

Packaging 40

Packaging Retail Edibles Wellness and Beauty 40

Kind Meds (Cannabis Education Blog)

FEBRUARY 20, 2023

This is true whether you prefer to smoke cured flower, vape cannabis concentrates , use medicinal cannabis topicals, or consume cannabis edibles. Consistent techniques when it comes to growing, collection, handling, and more are necessary for quality products.

Indica 52

Indica Hybrid Vaping Sativa 52

Cannabis Law Report

JANUARY 30, 2020

Likely under the auspices of public safety and assuring that cannabis is not diverted into the black market, the proposed law allows only certified patients to grow their own cannabis at home for medical use. OCM will also have authority over the final packaging and labeling requirements for such products. Adult-Use Licenses.

Programs 64

Programs Retail Cultivation Legislation 64

Cannabis Law Report

JANUARY 30, 2020

Likely under the auspices of public safety and assuring that cannabis is not diverted into the black market, the proposed law allows only certified patients to grow their own cannabis at home for medical use. OCM will also have authority over the final packaging and labeling requirements for such products. Adult-Use Licenses.

Programs 59

Programs Retail Cultivation Legislation 59

Otherside Farms

DECEMBER 10, 2019

The safety and risks of CBD for dogs haven’t but been researched. One way to avoid harmful ingredients is to use products with a certificate of research or COA (the batch variety on the COA ought to match the quantity on the product’s label or packaging). Drowsiness: Doghouse owners have used CBD to treat anxiety.

Oil 18

Oil CBD Pets Blood Pressure 18

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). With our extensive preclinical development package in hand, we are positioned to efficiently pursue additional indications for INM-755. For more information, visit www.inmedpharma.com.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

JUNE 24, 2021

He had leased out some of his greenhouses to a medical marijuana collective and quickly saw the opportunity to switch over almost all the greenhouses. It’s important to always know your strengths and your weaknesses, so that you can collectively help the business be successful. CLR: How did you get started in Cannabis?

CBD 94

CBD Business THC Strains 94